Physician profile
Haley Patrick Hill
NPI 1003276312
$2,374.72
in general payments reported to CMS, 2019-2025
27 companies · $318 in 2025
The $318 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $824 · 2022: $584 · 2023: $414 · 2024: $235 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $967.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $967.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $424.32 | 2021-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $329.43 | 2021-2025 | Xtampza |
| Abbvie INC. | $248.38 | 2024-2025 | |
| Scilex Pharmaceuticals INC. | $235.71 | 2021-2025 | Ztlido |
| Amgen INC. | $134.36 | 2021-2022 | |
| Abbott Laboratories | $131.35 | 2021 | |
| Almatica Pharma LLC | $107.81 | 2022-2023 | Gralise |
| Saluda Medical Americas, INC. | $101.69 | 2023-2025 | Evoke Scs, Evoke |
| Biodelivery Sciences International, INC. | $86.16 | 2021 | |
| Redhill Biopharma INC. | $63.96 | 2021 | |
| Lilly USA, LLC | $56.46 | 2021-2023 | Emgality, Reyvow |
| Avanir Pharmaceuticals, INC. | $54.39 | 2022 | |
| Relievant Medsystems, INC. | $51.42 | 2023 | Intracept |
| Averitas Pharma INC. | $45.03 | 2023-2024 | Qutenza |
| Nevro Corp. | $44.31 | 2021-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $40.28 | 2022 | |
| Grt US Holding, INC. | $36.59 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $28.04 | 2021 | |
| Vertos Medical, INC. | $26.30 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $19.37 | 2025 | |
| Lundbeck LLC | $18.36 | 2021 | |
| Spr Therapeutics, INC | $17.92 | 2024 | Sprint Pns System |
| Medtronic, INC. | $15.88 | 2022 | |
| Azurity Pharmaceuticals, INC. | $15.28 | 2023 | Horizant |
| Teva Pharmaceuticals USA, INC. | $14.82 | 2021 | |
| Pfizer INC. | $14.81 | 2021 | |
| Arbor Pharmaceuticals, INC. | $12.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.